SynDaver Labs Net Worth Shark Tank Update 2025

Christopher Sakezles is a scientist. He invented synthetic cadavers for medical education. These cadavers replace live humans and real cadavers. His invention helps with trauma training and surgical education. It is also useful for testing medical devices. Christopher founded SynDaver Labs to sell these products. He appeared on Shark Tank in Season 6. He asked for $3 million.

He offered 10 percent equity in his company. The Sharks were impressed by the technology. Will the entrepreneur get a deal on Shark Tank? Check out SynDaver Labs update to find out!

SynDaver Labs Net Worth Shark Tank Update 2025

Christopher Sakezles went on Shark Tank asking for $3,000,000 for 10% of his company. This meant he thought his business was worth $30,000,000. He made a deal with Robert Herjavec for $3,000,000 for 25%, lowering the valuation to $12,000,000. The episode was aired on May 8, 2014. The synthetic human and animal model company remains active with large research contracts and global expansion. Using the default 10% yearly growth method, the current net worth of SynDaver Labs is estimated to be around $45–50 million in 2025.

SynDaver Labs has done very well after Shark Tank. The company is still active today. It continues to produce synthetic cadavers and body parts. These products are sold to hospitals, schools, and medical companies. The company makes more than $10 million every year. It has become a leader in the medical education industry.

SynDaver Labs is even thinking about becoming a publicly traded company. This would allow more people to invest in the business. The company sells products through its website. Its cadavers are used all over the world. SynDaver Labs is still growing.

Yes SynDaver Labs got a deal on Shark Tank. Christopher asked for $3 million. He offered 10 percent equity in his company. Robert Herjavec made an offer. He asked for 35 percent equity. Christopher said that was too much. Robert lowered his request to 25 percent.

Christopher accepted this offer. This deal helped SynDaver Labs grow. The funding allowed the company to expand its operations. It also helped improve the products.

Shark(s) name	Offer & Demand	Counteroffer	Accepted?
Barbara Corcoran	out	N/A	N/A
Lori Greiner	Out	N/A	N/A
Kevin O’Leary	Out	N/A	N/A
Robert Herjavec	$3,000,000 for 35% equity	$3,000,000 for 25% equity	yes
Mark Cuban	Out	N/A	N/A

SynDaver Labs Shark Tank pitch

Christopher Sakezles is the founder of SynDaver Labs. He is a scientist with a passion for innovation. He wanted to solve a big problem. In the medical field, live humans and real cadavers are used for training. This has many issues. Real cadavers are expensive. They are not reusable. Live humans and animals are hard to use for testing. Christopher wanted to create a better solution. He invented synthetic cadavers.

These products look and feel like real human bodies. They can be used for training and testing. They are reusable. This makes them a better option than real cadavers. Christopher faced many challenges in the beginning. Creating synthetic cadavers was not easy. The materials had to feel like human tissue. They also had to work on different kinds of surgeries. Christopher worked hard to perfect the design.

Another challenge was cost. Each cadaver costs around $40,000 to produce. Christopher had to find buyers who could afford the product. He focused on hospitals and medical schools. Building the business took time. Christopher had to convince people to use his products. He also had to compete with traditional methods. Despite these challenges, Christopher stayed focused. He believed in his idea.

Christopher Sakezles appeared on Shark Tank with his synthetic cadavers. He brought a full display to show the Sharks. The display included cadavers and body parts. Christopher explained how his product worked. The synthetic cadavers are made to feel like real human tissue. They can be used for training and testing. They are also reusable. This makes them better than real cadavers. He told the Sharks about the cost.

A synthetic cadaver costs $40,000. Real cadavers cost between $5,000 and $10,000. But synthetic cadavers last longer. They are also more versatile. Christopher asked for $3 million. He offered 10 percent equity. He wanted the money to grow his business. He explained that his company was the only one in the world making these products. He held 10 patents for his inventions.

The Sharks were impressed by the technology. But they had many questions. They wanted to know more about the business.

The Sharks had many questions about SynDaver Labs. They wanted to understand the business better. They asked how the synthetic cadavers worked. Christopher explained that they were made to feel like live tissue. They could be used for any kind of surgery. This made them perfect for training. The Sharks asked about customers. Christopher said he sold his products to hospitals and medical schools.

These were the main buyers. They asked about competitors. Christopher said his company was the only one making these products. This made SynDaver Labs unique. The Sharks wanted to know about pricing. Christopher said each cadaver cost $40,000. This was more expensive than real cadavers. But synthetic cadavers were reusable. This made them a better investment over time. They also asked about revenue.

Christopher did not share exact numbers. But he said the company was growing. The Sharks had concerns about the investment. Some felt the business was too risky. They wanted to know how quickly they could get their money back.

The Sharks had mixed responses to SynDaver Labs. Barbara Corcoran was the first to drop out. She said Christopher would not be a good partner. Lori Greiner also dropped out. She felt the investment was too risky. She did not think it was a safe way to get her money back. Kevin O’Leary agreed with Lori. He did not see a quick return on the investment. He also dropped out. Mark Cuban shared his thoughts.

He said the business had potential. But he felt it was too risky. He decided not to invest .Robert Herjavec was the only Shark interested. He made an offer. He asked for 35 percent equity. Christopher said that was too much. He countered. Robert made a second offer. He asked for 25 percent equity. Christopher accepted this offer.

What Went Wrong With SynDaver Labs  On Shark Tank?

Nothing went wrong for SynDaver Labs on Shark Tank. The company received an offer. Christopher accepted the deal. Howeve,r some Sharks had concerns. They felt the business was too risky. Barbara Corcoran did not trust Christopher as a partner. Lori Greiner and Kevin O’Leary were worried about the investment. They wanted a quicker return.

Mark Cuban also felt the risk was too high. These concerns kept most Sharks from investing. But Robert Herjavec saw potential in the business.

Product Availability

SynDaver Labs produces synthetic cadavers. These cadavers are used for medical training and testing. They look and feel like real human bodies. They can be used for any kind of surgery. The cadavers cost $40,000 each. This is more expensive than real cadavers. But synthetic cadavers are reusable. This makes them a better option over time. The products are sold through the SynDaver Labs website.

Hospitals, schools, and medical companies are the main buyers.SynDaver Labs continues to expand. Its products are used all over the world. The company is thinking about becoming publicly traded. This would help it grow even more.

Conclusion

SynDaver Labs had a successful journey on Shark Tank. Christopher Sakezles presented an innovative product. He asked for $3 million. He accepted a deal with Robert Herjavec for 25 percent equity. The company has done well since then. It earns over $10 million every year. Its synthetic cadavers are used around the world. The company may even become publicly traded in the future.

SynDaver Labs continues to grow. Its products help improve medical education. Christopher’s invention is making a big impact.